Jianpei Xu
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Neurological Disease Mechanisms and Treatments 2
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 2
-
- Nanoplatforms for cancer theranostics 3
-
- Extracellular vesicles in disease 5
- RNA Interference and Gene Delivery 5
-
- Mesenchymal stem cell research 3
-
- Immune cells in cancer 2
- Partner nations
- ChinaSouth KoreaMacao
In The Last Decade
Jianpei Xu
12 papers receiving 654 citations
Peers
Comparison fields: 5 of 74
- Neurology 142
- Biomaterials 206
- Developmental Neuroscience 24
- Biomedical Engineering 252
- Molecular Biology 310
Countries citing papers authored by Jianpei Xu
This map shows the geographic impact of Jianpei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianpei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianpei Xu more than expected).
Fields of papers citing papers by Jianpei Xu
This network shows the impact of papers produced by Jianpei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianpei Xu. The network helps show where Jianpei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianpei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 28 | |
| 2 | 2023 | 49 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 20 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 26 | |
| 7 | 2023 | 49 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 44 | |
| 11 | 2021 | 0 | |
| 12 | 2020 | 21 | |
| 13 | 2019 | 157 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 240 |
About Jianpei Xu
Jianpei Xu is a scholar working on Neurology, Genetics, Developmental Neuroscience, Biomaterials and Immunology, having authored 15 papers that have together received 662 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), RNA Interference and Gene Delivery (5 papers), Mesenchymal stem cell research (3 papers), Nanoplatforms for cancer theranostics (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Neurology (142 citations), Biomaterials (206 citations), Developmental Neuroscience (24 citations), Biomedical Engineering (252 citations) and Molecular Biology (310 citations). Jianpei Xu has collaborated with scholars based in China, South Korea and Macao. Frequent co-authors include Wei Lv, Hongliang Xin, Qunwei Xu, Xinrui Li, Xiaoqi Wang, Quanyin Hu, Haoyuan Yin, Xiao-Qi Wang, Xiang Cao and Zhen Gu. Their work appears in journals such as ACS Nano, Small, Acta Pharmaceutica Sinica B, Nature Communications and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.